| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0009-9120(94)90015-9 |
| P698 | PubMed publication ID | 7520846 |
| P50 | author | Eleftherios P. Diamandis | Q37383505 |
| P2093 | author name string | H Yu | |
| D J Sutherland | |||
| P433 | issue | 2 | |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 75-79 | |
| P577 | publication date | 1994-04-01 | |
| P1433 | published in | Clinical Biochemistry | Q5133749 |
| P1476 | title | Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age | |
| P478 | volume | 27 |
| Q71167693 | . . . and secreted tumour suppressors |
| Q24654651 | A novel protease homolog differentially expressed in breast and ovarian cancer |
| Q73150613 | A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo |
| Q83875633 | Breast metastasis from prostate cancer and interpretation of immunoreactivity to prostate-specific antigen |
| Q40717386 | Characterization of androgen receptor and nuclear receptor co-regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3. |
| Q51829513 | Developmental validation of RSID™-Semen: a lateral flow immunochromatographic strip test for the forensic detection of human semen. |
| Q41495930 | Diagnostic and prognostic markers for human prostate cancer |
| Q51674069 | Diagnostic value of prostate-specific antigen (PSA) and free prostate specific antigen (fPSA) in women with ovulatory and anovulatory polycystic ovary syndrome. |
| Q40876820 | Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines |
| Q36408671 | Does Rigid Cystoscopy Affect the Total Serum Prostate-Specific Antigen Levels? |
| Q73435411 | ELISA for a complexed antigen with a monoclonal antibody blocking reaction with the free antigen-assay-specific for complexed prostate-specific antigen |
| Q36619873 | Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination. |
| Q35838103 | Enzymatic activity of free-prostate-specific antigen (f-PSA) is not required for some of its physiological activities |
| Q44124099 | Ethnic variation in kallikrein expression in nipple aspirate fluid |
| Q36621078 | Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions |
| Q36618953 | Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer |
| Q57794962 | Expression of prostate-specific antigen and human glandular kallikrein 2 in the thyroid gland |
| Q77214924 | Free/total prostate-specific antigen ratio can prevent unnecessary prostate biopsies |
| Q41727247 | IGF-independent regulation of breast cancer growth by IGF binding proteins |
| Q41693162 | IGFBPs and neoplastic models. New concepts for roles of IGFBPs in regulation of cancer cell growth |
| Q36081213 | Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators |
| Q71344132 | Immunohistochemical labelling for prostate specific antigen in non-prostatic tissues |
| Q73207831 | Immunohistochemical labelling for prostate-specific antigen in breast carcinomas |
| Q36421789 | Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues |
| Q52958555 | Improving the Specificity of the Prostate-Specific Antigen Substrate Glutaryl-Hyp-Ala-Ser-Chg-Gln as a Promoiety. |
| Q48066544 | Influence of dioxin exposure upon levels of prostate-specific antigen and steroid hormones in Vietnamese men. |
| Q36643689 | Measurement of serum total and free prostate-specific antigen in women with colorectal carcinoma |
| Q33543083 | Molecular chemotherapy for breast cancer |
| Q40400486 | Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. |
| Q36431227 | Molecular forms of prostate-specific antigen in the serum of women with benign and malignant breast diseases |
| Q57943425 | NONPROSTATIC SOURCES OF PROSTATE-SPECIFIC ANTIGEN |
| Q41409581 | New diagnostic applications of prostate-specific antigen |
| Q36622022 | Optimization of the reverse transcriptase polymerase chain reaction for the detection of circulating prostate cells |
| Q57943676 | Oral Contraceptive-induced Expression of Prostate-specific Antigen in the Female Breast |
| Q35609528 | PSA markers in prostate cancer detection |
| Q48018300 | Percent free prostate-specific antigen: the next frontier in prostate-specific antigen testing |
| Q34612314 | Predictive and prognostic markers for invasive breast cancer |
| Q71702882 | Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue |
| Q57943178 | Prostate specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease |
| Q47910695 | Prostate specific antigen production by breast tumors after induction with oral contraceptives |
| Q57082655 | Prostate specific antigen — a new constituent of breast cyst fluid |
| Q24801573 | Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics? |
| Q36115207 | Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours |
| Q57942649 | Prostate-specific antigen and insulin-like growth factor binding protein-3 in nipple aspirate fluid are associated with breast cancer |
| Q73272401 | Prostate-specific antigen found in type I breast cyst fluids is a secretory product of the apocrine cells lining breast gross cysts |
| Q50988829 | Prostate-specific antigen in amniotic fluid of normal and abnormal pregnancies. |
| Q41192379 | Prostate-specific antigen in breast cyst fluid: possible role of prostate-specific antigen in hormone-dependent breast cancer |
| Q73764126 | Prostate-specific antigen in female urine: a prospective study involving 217 women |
| Q71154495 | Prostate-specific antigen in nipple aspirate |
| Q36081111 | Prostate-specific antigen in serum of women with breast cancer |
| Q41051526 | Prostate-specific antigen induction by a steroid hormone in T47D cells growing in SCID mice |
| Q34390618 | Prostate-specific antigen kallikrein and the heart |
| Q38571586 | Prostate-specific antigen kallikrein: from prostate cancer to cardiovascular system |
| Q92636843 | Proteolytic Regulation of Parathyroid Hormone-Related Protein: Functional Implications for Skeletal Malignancy |
| Q71343219 | Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids |
| Q36136069 | Reverse transcriptase-polymerase chain reaction for prostate-specific antigen may be a prognostic indicator in breast cancer |
| Q37224565 | Second cancers in patients with male breast cancer: a literature review |
| Q34510265 | Separation methods applicable to prostate cancer diagnosis and monitoring therapy. |
| Q36116069 | Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer |
| Q84209959 | Synchronous bilateral breast cancer in a male patient following hormone therapy for prostate cancer |
| Q33884420 | The diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast. |
| Q34552414 | The expression of prostate-specific antigen in invasive breast carcinoma and its relationship with routine clinicopathologic parameters |
| Q35080570 | The role of circulating IGF-I: lessons from human and animal models |
| Q34447102 | The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease. |
Search more.